510(k) Report

510(k) · Cleared

Recalled · Class II · 2023

Q2 Intravenous Adminstration Sets and Extension Sets

K151079510(k) TraditionalCleared Sep 30, 2015161-day reviewClass II21 CFR 880.5440Recalls 1

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Quest Medical, Inc. · FPA Set, Administration, Intravascular

Cleared on Sep 30, 2015 as substantially equivalent to K800825 (Quest Medical, Inc., 1980) and 1 other predicate after a 161-day review. Its family tree reaches back 2 generations to 2000. 1 later device descends from it. It has been recalled once.

Decided
Sep 30, 2015
Review
161 days
Class
Class II
Product code
FPA
Recalls
1
Predicates
2

Its longest line of descent runs back 2 generations to K003225 (2000). 3 ancestors in all, the oldest K800825 (1980). 1 later device descends from it, 1 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 1980: 1 other ancestor2016: 1 descendant clearedK003225 · Solution Administration Sets with Capless Luer Activated Valve · Baxter Healthcare Corp · 2000 · recalledK040385 · Multiport Manifold Set with Swabable Valves, Model 9900 · Quest Medical, Inc. · 200419801990200020102020
Other ancestors, by generationDescendants, by generation 1 generation back: 1 other ancestor 1 generation forward: 1 descendant K040385 · Multiport Manifold Set with Swabable Valves, Model 9900 · Quest Medical, Inc. · 2004K003225 · Solution Administration Sets with Capless Luer Activated Valve · Baxter Healthcare Corp · 2000 · recalled0
  1. Root · 2 generations backK003225 Solution Administration Sets with Capless Luer Activated ValveBaxter Healthcare Corp · 2000 · Recalled
  2. 1 generation backK040385 Multiport Manifold Set with Swabable Valves, Model 9900Quest Medical, Inc. · 2004
  3. This deviceK151079 Q2 Intravenous Adminstration Sets and Extension SetsQuest Medical, Inc. · 2015
  4. Descendant · cites it directly · 0 of its ownK162304 Q2 Multiport IV Administration Sets and Extension Sets, Checkmate…Quest Medical, Inc. · 2016

Most influential descendants

Showing 1 of 1 · See all
  • K162304Q2 Multiport IV Administration Sets and Extension Sets, Checkmate Multiport IV…Quest Medical, Inc. · 2016 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K003225Solution Administration Sets with Capless Luer Activated ValveBaxter Healthcare Corp200018
−1K040385Multiport Manifold Set with Swabable Valves, Model 9900Quest Medical, Inc.2004—
0 (this device)K151079Q2 Intravenous Adminstration Sets and Extension SetsQuest Medical, Inc.2015—
+1K162304Q2 Multiport IV Administration Sets and Extension Sets, Checkmate Multiport IV…Quest Medical, Inc.2016—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
198010

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201610
FIG. 1 — Lineage of K151079, 2000–2016Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in FPA? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new FPA device

  1. #1 K243841 Sparta Infusion Set for Insulinscore 13.4 · 3 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K800825Extension Set Quest Code #3000
Summary page 4
…Set Product Code: FPA, FPK Regulation Number: 880.5440 Class: II PREDICATE DEVICES: Quest Medical, Inc. Extension Sets (K800825) Quest Medical, Inc. IV Administration Sets (K040385) DESCRIPTION: Sterile, single use no…
Quest Medical, Inc.1980—
*K040385Multiport Manifold Set with Swabable Valves, Model 9900
Summary page 4
…lass: II PREDICATE DEVICES: Quest Medical, Inc. Extension Sets (K800825) Quest Medical, Inc. IV Administration Sets (K040385) DESCRIPTION: Sterile, single use non-pyrogenic intravenous fluid administration sets wit…
Quest Medical, Inc.2004—

Also cleared against K800825: 1 other device →

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K162304Q2 Multiport IV Administration Sets and Extension Sets, Checkmate Multiport IV…Quest Medical, Inc.20160

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Jul 14, 2023Class IIZ-0197-2024Material/Component ContaminationFor administration of intravenous fluids to a patient s vascular system utilizing needle-free components and I.V. manifold for multiple simultaneous intravenous therapy via gravity, syringe, or infusion pump. Use of a needle-free system…

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 15 years and passes through 2 companies; a new generation was cleared every 11.5 years on median.
  • 1 of the 3 ancestors has a recall of any class.
  • Of its descendants, K162304 (Quest Medical, Inc., 2016) has gone furthest, with 0 descendants of its own.
  • 1 other device also cites its predicate K800825.

How does its category compare?

All FPA devices

FPA Set, Administration, Intravascular: FDA decisions, review times, recalls and adverse event reports over 20 years. 2015, this device’s year, is highlighted.

FDA decisions per year · FPA

11in 2025

2007: 162008: 182009: 102010: 232011: 122012: 212013: 132014: 222015: 172016: 122017: 172018: 42019: 72020: 102021: 132022: 142023: 142024: 72025: 112026 (partial year): 5
2007high 23 (2010) · low 4 (2018)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · FPA

225in 2025

2007: 75 days median2008: 89 days median2009: 166 days median2010: 120 days median2011: 87 days median2012: 96 days median2013: 90 days median2014: 89 days median2015: 123 days median2016: 195 days median2017: 240 days median2018: 177 days median2019: 161 days median2020: 327 days median2021: 186 days median2022: 213 days median2023: 340 days median2024: 244 days median2025: 225 days median2026 (partial year): 266 days median
2007high 340 (2023) · low 75 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · FPA

98in 2025

2007: 172008: 152009: 1662010: 582011: 282012: 16, 4 Class I2013: 642014: 242015: 62016: 102017: 132018: 42019: 132020: 1072021: 12022: 9, 5 Class I2023: 12, 4 Class I2024: 13, 1 Class I2025: 98, 1 Class I2026 (partial year): 10, 2 Class I
2007high 166 (2009) · low 1 (2021)2026

Class I (17 since 2007) Class II/III not classified

Adverse event reports per year · FPA

34,506in 2025

2007: 1,4992008: 1,9412009: 2,5122010: 2,5372011: 4,4072012: 4,9302013: 4,6512014: 4,6952015: 6,6252016: 8,4702017: 6,4622018: 6,5742019: 11,2272020: 9,5632021: 10,4142022: 13,3932023: 10,9162024: 47,2102025: 34,506
2007high 47,210 (2024) · low 1,499 (2007)2025

MAUDE reports naming product code FPA, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071675171,499
20081889151,941
2009101661662,512
201023120582,537
20111287284,407
2012219616 (4)4,930
20131390644,651
20142289244,695
20151712366,625
201612195108,470
201717240136,462
2018417746,574
201971611311,227
2020103271079,563
202113186110,414
2022142139 (5)13,393
20231434012 (4)10,916
2024724413 (1)47,210
20251122598 (1)34,506
2026526610 (2)—

What is it indicated for?

For administration of intravenous fluids to a patient’s vascular system utilizing needleless components and an I.V. manifold for multiple simultaneous intravenous therapy via gravity, syringe, or infusion pump.

Use of a needle-free system may aid in the prevention of needle-stick injuries.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K151079: Q2 Intravenous Adminstration Sets and Extension Sets.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K151079

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026